Dissolution-Controlled Nanocrystalline Rifapentine Formulation for Tuberculosis Treatment
Nisha Sanjay Barge, Yeswanth Chakravarthy Kalapala, Pranshu Rajurkar, Ameya Atul Dravid, Naveen Kumar Bhukya, Rituparna Saha, Sanjay V, Harinath Chakrapani, Rachit Agarwal
This study develops dissolution-controlled nanocrystalline rifapentine formulations that maintain therapeutic concentrations for over a week, showing efficacy in TB prevention and treatment in mice.
bioRxiv · Aug 20, 2026 · PreprintBioengineering